SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

77,008.91 -255.60
( -0.33%)

Global Indices

Nasdaq

53,569.16 -21.28
(-0.04%)

Dow Jones

7,731.77 -20.22
(-0.26%)

Hang Seng

66,147.06 -258.50
(-0.39%)

Nikkei 225

10,816.31 23.77
(0.22%)

Forex

USD-INR

95.48 0.22
(0.23%)

EUR-INR

111.24 0.16
(0.15%)

GBP-INR

129.74 0.04
(0.03%)

JPY-INR

0.60 0.00
(0.12%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Mercury Laboratories Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

538964

INE947G01011

484

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

21.14

92.84

EPS(TTM)

Face Value()

Div & Yield %

36.59

0.45

Back

Syngene International reports consolidated net loss of Rs 9.00 crore in the June 2026 quarter

Jul 30,2026

Net loss of Syngene International reported to Rs 9.00 crore in the quarter ended June 2026 as against net profit of Rs 86.70 crore during the previous quarter ended June 2025. Sales declined 15.84% to Rs 736.00 crore in the quarter ended June 2026 as against Rs 874.50 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	736.00	874.50	-16
OPM %	12.34	23.60	-
PBDT	106.50	212.50	-50
PBT	-5.70	101.30	PL
NP	-9.00	86.70	PL

77,008.91 -255.60 ( -0.33%)

53,569.16 -21.28 (-0.04%)

7,731.77 -20.22 (-0.26%)

66,147.06 -258.50 (-0.39%)

10,816.31 23.77 (0.22%)

95.48 0.22 (0.23%)

111.24 0.16 (0.15%)

129.74 0.04 (0.03%)

0.60 0.00 (0.12%)